1-3 of 3
Lingshuang Sheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Auto-HSCT Vs CAR-T Cell Therapy for Paients with Relapsed/Refractory DLBCL in Partial Remission with Deauville Score of 4 or 5 after Salvage Chemotherapy

Siyuan Chen, Li Wang, Pengpeng Xu, Shu Cheng, Wei Tang, Wen Wu, Mengmeng Ji, Zhong Zheng, Zixun Yan, Lingshuang Sheng, Yige Shen, Weili Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6553.
https://doi.org/10.1182/blood-2024-203842
Published: 2024
Journal Articles

Investigating Prognostic Value of Immunoglobulin Next-Generation Sequencing in B Cell Non-Hodgkin Lymphoma Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy

Yi-Lun Zhang, Lingshuang Sheng, Rong Shen, Wen Wu, Xin Zheng, Li Wang, Shu Cheng, Peng-Peng Xu, Qi-Jie Jian, Bo Peng, Ke Zhang, Fei Pang, Kai Wang, Zi-Xun Yan, Wei-Li Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6208.
https://doi.org/10.1182/blood-2024-209889
Published: 2024
Journal Articles

LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study

Lingshuang Sheng, Zixun Yan, Li Wang, Wen Wu, Yilun Zhang, Rong Shen, Weiguo Cao, Lei Li, Sheng Chen, Xufeng Jiang, Hongmei Yi, Qi Song, Li Wang, Shu Cheng, Pengpeng Xu, Xuanming Yang, Yuxiang Zhu, Xikang Xu, Fuzhe Wang, Jianyong Li, Wei Li Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 4822.
https://doi.org/10.1182/blood-2024-198296
Published: 2024